Prevenciónal a tüdorák okozta halálozás visszaszorításáért

Translated title of the contribution: Reducing lung cancer mortality through prevention

G. Kovács, G. Ostoros, G. Pataki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Effective therapy for lung cancer is yet unknown and the role of prevention has continuously increased. In practice, primary prevention of lung cancer means the reduction of smoking either by cessation or by patient education. Screening for lung cancer, considered as a secondary prevention measure, has long been debated. The previously negative attitude for screening has slowly changed in the past years. New studies have been organised recently to make screening more effective. In high risk groups, helical CT-scans with low dose X-ray exposure are preferred and the effectivity of sputum citology completed with immunocytochemical tests is under investigation. Determining the risk group, we focus on age, smoking history, airway obstruction and certain tumour markers. With the help of traditional chest X-rays approximately one third of new cases of lung cancer are discovered in Hungary. Our reasonable target is to identify 60-70% of the new NSCLC cases by risk group screening (age>40 years, smoking>20 P.Y., decrease of FEV1>15%, family lung cancer history and previous asbestos exposure) and by organising population screening more effectively.

Original languageHungarian
Pages (from-to)268-273
Number of pages6
JournalLege Artis Medicinae
Volume11
Issue number4
Publication statusPublished - 2001

Fingerprint

Lung Neoplasms
Mortality
Smoking
X-Rays
Hungary
Spiral Computed Tomography
Asbestos
Airway Obstruction
Smoking Cessation
Patient Education
Primary Prevention
Tumor Biomarkers
Secondary Prevention
Focus Groups
Sputum
Thorax
Age Groups
History
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevenciónal a tüdorák okozta halálozás visszaszorításáért. / Kovács, G.; Ostoros, G.; Pataki, G.

In: Lege Artis Medicinae, Vol. 11, No. 4, 2001, p. 268-273.

Research output: Contribution to journalArticle

Kovács, G. ; Ostoros, G. ; Pataki, G. / Prevenciónal a tüdorák okozta halálozás visszaszorításáért. In: Lege Artis Medicinae. 2001 ; Vol. 11, No. 4. pp. 268-273.
@article{6555b3353b1f4e6fba60e2c0c7299fc3,
title = "Prevenci{\'o}nal a t{\"u}dor{\'a}k okozta hal{\'a}loz{\'a}s visszaszor{\'i}t{\'a}s{\'a}{\'e}rt",
abstract = "Effective therapy for lung cancer is yet unknown and the role of prevention has continuously increased. In practice, primary prevention of lung cancer means the reduction of smoking either by cessation or by patient education. Screening for lung cancer, considered as a secondary prevention measure, has long been debated. The previously negative attitude for screening has slowly changed in the past years. New studies have been organised recently to make screening more effective. In high risk groups, helical CT-scans with low dose X-ray exposure are preferred and the effectivity of sputum citology completed with immunocytochemical tests is under investigation. Determining the risk group, we focus on age, smoking history, airway obstruction and certain tumour markers. With the help of traditional chest X-rays approximately one third of new cases of lung cancer are discovered in Hungary. Our reasonable target is to identify 60-70{\%} of the new NSCLC cases by risk group screening (age>40 years, smoking>20 P.Y., decrease of FEV1>15{\%}, family lung cancer history and previous asbestos exposure) and by organising population screening more effectively.",
keywords = "Lung cancer, Prevention, Screening, Smoking",
author = "G. Kov{\'a}cs and G. Ostoros and G. Pataki",
year = "2001",
language = "Hungarian",
volume = "11",
pages = "268--273",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "4",

}

TY - JOUR

T1 - Prevenciónal a tüdorák okozta halálozás visszaszorításáért

AU - Kovács, G.

AU - Ostoros, G.

AU - Pataki, G.

PY - 2001

Y1 - 2001

N2 - Effective therapy for lung cancer is yet unknown and the role of prevention has continuously increased. In practice, primary prevention of lung cancer means the reduction of smoking either by cessation or by patient education. Screening for lung cancer, considered as a secondary prevention measure, has long been debated. The previously negative attitude for screening has slowly changed in the past years. New studies have been organised recently to make screening more effective. In high risk groups, helical CT-scans with low dose X-ray exposure are preferred and the effectivity of sputum citology completed with immunocytochemical tests is under investigation. Determining the risk group, we focus on age, smoking history, airway obstruction and certain tumour markers. With the help of traditional chest X-rays approximately one third of new cases of lung cancer are discovered in Hungary. Our reasonable target is to identify 60-70% of the new NSCLC cases by risk group screening (age>40 years, smoking>20 P.Y., decrease of FEV1>15%, family lung cancer history and previous asbestos exposure) and by organising population screening more effectively.

AB - Effective therapy for lung cancer is yet unknown and the role of prevention has continuously increased. In practice, primary prevention of lung cancer means the reduction of smoking either by cessation or by patient education. Screening for lung cancer, considered as a secondary prevention measure, has long been debated. The previously negative attitude for screening has slowly changed in the past years. New studies have been organised recently to make screening more effective. In high risk groups, helical CT-scans with low dose X-ray exposure are preferred and the effectivity of sputum citology completed with immunocytochemical tests is under investigation. Determining the risk group, we focus on age, smoking history, airway obstruction and certain tumour markers. With the help of traditional chest X-rays approximately one third of new cases of lung cancer are discovered in Hungary. Our reasonable target is to identify 60-70% of the new NSCLC cases by risk group screening (age>40 years, smoking>20 P.Y., decrease of FEV1>15%, family lung cancer history and previous asbestos exposure) and by organising population screening more effectively.

KW - Lung cancer

KW - Prevention

KW - Screening

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0034972827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034972827&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034972827

VL - 11

SP - 268

EP - 273

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 4

ER -